Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Feb;56(2):209–218. doi: 10.1111/j.1476-5381.1976.tb07444.x

Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.

F Michal, M Motamed
PMCID: PMC1666874  PMID: 1252669

Abstract

1 The interaction of effects between 5-hydroxytryptamine (5-HT) and adenosine diphosphate (ADP) on human or rabbit platelets was investigated in vitro. The initial platelet shape change and their aggregation were measured in stirred, citrated platelet-rich plasma (PRP) at 37 degrees C by recording the rate and extent of changes in light scattering and light transmission. 2 Both the velocity and extent of aggregation and the velocity and extent of the rapid morphological change caused by ADP were enhanced by simultaneous addition of 5-HT. Methysergide but not imipramine inhibited the 5-HT effects. 3 Platelets were made refractory to the aggregating and shape changing effect of either ADP or 5-HT by repeated aggregation with the particular agent; platelets made refractory to ADP retained their responsiveness to 5-HT and platelets made refractory to 5-HT responded to ADP. Platelets pre-incubated for 3-10 min with 5-HT without aggregation showed greatly reduced aggregation on subsequent addition of ADP. Methysergide inhibited all the effects of 5-HT whilst imipramine was inactive. 4 When the shape change or aggregation of platelets induced by ADP was submaximal, addition of 5-HT increased it further. Pre-incubation of PRP with 5-HT before the addition of ADP resulted in failure of the secondary induction of aggregation or shape change by 5-HT. The secondary induction by 5-HT also did not occur in the presence of methysergide; imipramine had no inhibitory effect. Similar secondary induction of aggregation was shown by adrenaline injected during aggregation by ADP; the adrenaline effect was removed by phentolamine but not by propranolol. 5 Our results show that the initial change in shape of platelets and their aggregation can be induced by ADP or 5-HT in specific manner. The interaction of the effect of these substances on platelets can result in either increase in platelet sensitivity or, under certain conditions, decrease in platelet responsiveness. The increase or depression of platelet reactivity appears to be a highly specific effect and is probably mediated at specific receptors involved with platelet activation.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V., GILLSON R. E. Studies on the uptake of 5-hydroxytryptamine by blood platelets. J Physiol. 1959 Jun 11;146(3):472–491. doi: 10.1113/jphysiol.1959.sp006206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BORN G. V., INGRAM G. I., STACEY R. S. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets. Br J Pharmacol Chemother. 1958 Mar;13(1):62–64. doi: 10.1111/j.1476-5381.1958.tb00191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baumgartner H. R., Born G. V. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968 Apr 13;218(5137):137–141. doi: 10.1038/218137a0. [DOI] [PubMed] [Google Scholar]
  4. Baumgartner H. R., Born G. V. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. J Physiol. 1969 Apr;201(2):397–408. doi: 10.1113/jphysiol.1969.sp008762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Born G. V., Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature. 1967 Sep 2;215(5105):1027–1029. doi: 10.1038/2151027a0. [DOI] [PubMed] [Google Scholar]
  6. Born G. V., Juengjaroen K., Michal F. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Br J Pharmacol. 1972 Jan;44(1):117–139. doi: 10.1111/j.1476-5381.1972.tb07244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Caen J. P., Michel H. Platelet shape change and aggregation. Nature. 1972 Nov 17;240(5377):148–149. doi: 10.1038/240148a0. [DOI] [PubMed] [Google Scholar]
  8. Da Prada M., Pletscher A. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes. Br J Pharmacol. 1968 Nov;34(3):591–597. doi: 10.1111/j.1476-5381.1968.tb08487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Evans R. J., Gordon J. L. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses. Br J Pharmacol. 1974 May;51(1):123P–123P. [PMC free article] [PubMed] [Google Scholar]
  10. HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Marmaras V. J., Mimikos N. Enzymic formation of serotonin in mammalian blood platelets and red cells. Experientia. 1971 Feb 15;27(2):196–197. doi: 10.1007/BF02145892. [DOI] [PubMed] [Google Scholar]
  12. Michal F., Born G. V. Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma. Nat New Biol. 1971 Jun 16;231(24):220–222. doi: 10.1038/newbio231220a0. [DOI] [PubMed] [Google Scholar]
  13. Michal F. D-receptor for serotonin on blood platelets. Nature. 1969 Mar 29;221(5187):1253–1254. doi: 10.1038/2211253a0. [DOI] [PubMed] [Google Scholar]
  14. Michal F., Penglis F. Inhibition of serotonin-induced platelet aggregation in relation to thrombus production. J Pharmacol Exp Ther. 1969 Apr;166(2):276–284. [PubMed] [Google Scholar]
  15. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  16. Paasonen M. K. Release of 5-hydroxytryptamine from blood platelets. J Pharm Pharmacol. 1965 Nov;17(11):681–697. doi: 10.1111/j.2042-7158.1965.tb07590.x. [DOI] [PubMed] [Google Scholar]
  17. Packham M. A., Guccione M. A., Chang P. L., Mustard J. F. Platelet aggregation and release: effects of low concentrations of thrombin or collagen. Am J Physiol. 1973 Jul;225(1):38–47. doi: 10.1152/ajplegacy.1973.225.1.38. [DOI] [PubMed] [Google Scholar]
  18. Pletscher A., da Prada M., Tranzer J. P. Transfer and storage of biogenic monoamines in subcellular organelles of blood platelets. Prog Brain Res. 1969;31:47–52. doi: 10.1016/s0079-6123(08)63226-4. [DOI] [PubMed] [Google Scholar]
  19. RAND M., REID G. Source of 'serotonin' in serum. Nature. 1951 Sep 1;168(4270):385–385. doi: 10.1038/168385b0. [DOI] [PubMed] [Google Scholar]
  20. Sinakos Z., Caen J. P. Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):99–111. [PubMed] [Google Scholar]
  21. Sneddon J. M. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973;1(2):151–198. doi: 10.1016/0301-0082(73)90019-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES